Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial of LASN01 in healthy subjects and patients with pulmonary fibrosis or thyroid eye disease has completed, assessin…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest [NA]
Completed Johns Hopkins trial evaluating oxygen delivery strategies. The study compares administered oxygen with high-flow ambient air at re…
-
CLINICAL_TRIALS withdrawal · 2024-12-10Clinical Trial Update: Safety of Nintedanib in Real World in China
The real-world safety study of nintedanib in China (NCT05676112) sponsored by Boehringer Ingelheim has been withdrawn.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT [Phase 1]
This Phase 1 trial compares the diagnostic value of two PET-CT tracers, 68Ga-FAPI-04 and 18F-FDG, for pulmonary fibrosis and is currently re…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland
This clinical trial update indicates ongoing recruitment for a study on precision diagnosis and care for families affected by pulmonary fibr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of SC1011 in healthy subjects has been completed.
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD
A completed Northwestern University study investigates unique pathogenic macrophages involved in systemic sclerosis-associated interstitial …
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Rehabilitation in Patients With Pulmonary Fibrosis
This clinical trial update concerns rehabilitation interventions for patients with pulmonary fibrosis; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders [EARLY_Phase 1]
This early-phase trial aims to optimize parameters for hyperpolarized gas MRI to image a broad range of lung disorders, informing imaging pr…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients [Phase 2]
Phase 2 trial update for BIO 300 oral suspension in previously hospitalized Long COVID patients; current status and results are not provided…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Digital Modeling of Thoracic CT and Pulmonary Fibrosis
This clinical trial in Paris investigates digital modeling of thoracic CT scans to study diffuse interstitial lung disease and pulmonary fib…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF [NA]
A completed clinical trial evaluating the impact of digital cognitive behavioral therapy (dCBT) on psychological symptom burden in adults wi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19 [Phase 2]
A Phase 2 trial evaluating VL-PX10 plus VL-P22 for Pulmonary Fibrosis related to COVID-19 has been suspended.
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung Patients [NA]
A clinical trial led by Istanbul Medipol University Hospital is evaluating whether exercise training improves quality of life and slows dise…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Advancing Symptom Alleviation With Palliative Treatment [NA]
A completed clinical trial is reported evaluating palliative treatment for symptom relief in patients with heart failure and chronic lung di…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease [NA]
A clinical trial evaluating telehealth and onsite maintenance exercise for people with chronic lung diseases, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial evaluating pirfenidone (Esbriet) for pulmonary fibrosis associated with coal workers' pneumoconiosis; the study has…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Covid-19 Respiratory Sequelae French Cohort
A completed French cohort study assessing long-term respiratory sequelae after COVID-19, including fibrosis evaluation and pulmonary functio…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Magnetic Resonance Lung Function Imaging Study of Pulmonary Fibrosis Combined With Emphysema Syndrome
This clinical trial update describes a magnetic resonance lung function imaging study investigating perfusion changes in patients with combi…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease [NA]
Clinical trial update describing a study on hyperpolarized 129Xe MRI to image lung function in healthy volunteers and patients with various …
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Pulmonary Fibrosis After Severe COVID-19 Pneumonia
A completed clinical trial (NCT06423560) evaluating pulmonary fibrosis after severe COVID-19 pneumonia has finished.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: 68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19
A completed clinical trial evaluating Ga-68 FAPI PET/CT imaging to detect ongoing fibroblast activity in individuals recovering from COVID-1…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis [Phase 3]
Phase 3 clinical trial evaluating nintedanib for SARS-CoV-2-induced pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Multiple Breath Washout as a Method for Diagnosing Lung Diseases
Completed clinical trial evaluating multiple breath washout as a diagnostic method for lung diseases, including pulmonary fibrosis, chronic …
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Colchicine and Post-COVID-19 Pulmonary Fibrosis [Phase 4]
A Phase 4 clinical trial update investigating colchicine for post-COVID-19 pulmonary fibrosis (interstitial pulmonary fibrosis).